XML 153 R25.htm IDEA: XBRL DOCUMENT v3.25.4
EARNINGS PER COMMON SHARE
12 Months Ended
Dec. 31, 2025
EARNINGS PER COMMON SHARE  
EARNINGS PER COMMON SHARE

NOTE 17 — EARNINGS PER COMMON SHARE

The Company uses the two-class method in the calculation of basic and diluted earnings per share. Under the two-class method, earnings available to common stockholders for the period are allocated between common stockholders and participating securities according to dividends declared (or accumulated) and participation rights in undistributed earnings. The factors used in the earnings per share calculation are as follows (in thousands, except per share data):

Year Ended December 31, 

  ​ ​ ​

  ​ ​ ​

2025

  ​ ​ ​

2024

  ​ ​ ​

2023

Basic

Net income per consolidated statements of income

$

71,098

$

66,686

$

77,268

Less:  Earnings allocated to participating securities

(365)

Net income available to common stockholders

$

71,098

$

66,686

$

76,903

Weighted average common shares outstanding including participating securities

10,594,606

11,179,074

11,112,572

Less:  Weighted average participating securities

(52,462)

Weighted average common shares outstanding

10,594,606

11,179,074

11,060,110

Basic earnings per common share

$

6.71

$

5.97

6.95

Diluted

Net income allocated to common stockholders

$

71,098

$

66,686

$

76,903

Weighted average common shares outstanding for basic earnings per common share

10,594,606

11,179,074

11,060,110

Add: Dilutive effects of assumed vesting of performance based restricted stock units

28,940

69,790

Add: Dilutive effects of assumed vesting of restricted stock units

118,124

76,149

Average shares and dilutive potential common shares

10,741,670

11,255,223

11,129,900

Dilutive earnings per common share

$

6.62

$

5.93

$

6.91

For the year ended December 31, 2025, all performance based restricted stock units and restricted stock units were considered in computing diluted earnings per common share. For the year ended December 31, 2024, 42,735 of  performance based restricted stock units were not considered in the calculation of diluted earnings per share as their inclusion would be anti-dilutive. For the year ended December 31, 2023, 248,234 of restricted stock units were not considered in the calculation of diluted earnings per share as their inclusion would be anti-dilutive.